Wnt genes and endocrine disruption of the female reproductive tract: A genetic approach

Molecular and Cellular Endocrinology

Volumn 158, Issue 1-2, 1999, Pages 1-5

  Sassoon, David ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

DES; Endocrine disrupter; Female reproductive tract; Patterning; Wnt signaling

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN; ESTROGEN RECEPTOR; STEROID RECEPTOR;

ARTICLE; EMBRYO; ENDOCRINE DISEASE; FEMALE; FEMALE GENITAL SYSTEM; FETUS; GENE CONTROL; GENITAL SYSTEM DISEASE; GENITAL TRACT CANCER; GYNECOLOGIC DISEASE; HUMAN; MODEL; MOUSE; MULTIGENE FAMILY; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UTERUS;

ANIMALS; CELL DIFFERENTIATION; ESTROGENS; FEMALE; GENITALIA, FEMALE; HUMANS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; UTERUS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0032722717     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00170-7     Document Type: Article

References (45)

1. Boutin E.L., Sanderson R.D., Bernfield M., Cunha G.R. Epithelial-mesenchymal interactions in uterus and vagina alter the expression of the cell surface proteoglycan, syndecan. Dev. Biol. 148(1):1991;63-74.
2. Ahlborg U.G., Lipworth L., Titus-Ernstoff L., Hsieh C.C., Hanberg A., Baron J., Trichopoulos D., Adami H.O. Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit. Rev. Toxicol. 25(6):1995;463-531.
3. Anderson C., Forsberg, J.-G., 1988. Induction of estrogen receptor, peroxidase activity, and epithelial abnormalities in the mouse uterovaginal epithelium after neonatal treatment with diethylstilbestrol. Terat. Carcinog. Mutag. 8, 347-361.
4. Baker N.E. Molecular cloning of sequences from wingless, a segment polarity gene in Drosophila: the spatial distribution of a transcript in embryos. EMBO J. 6:1987;1765-1773.
5. Behringer R.R. The mullerian inhibitor and mammalian sexual development. Philos. Trans. R Soc. Lond. B Biol. Sci. 350(1333):1995;285-288. discussion 289.
6. Behringer R.R., Finegold M.J., Cate R.L. Müllerian-inhibiting substance function during mammalian sexual development. Cell. 79(3):1994;415-425.
7. Boutin E.L., Battle E., Cunha G.R. The germ layer origin of mouse vaginal epithelium restricts its responsiveness to mesenchymal inductors: uterine induction. Differentiation. 49(2):1992;101-107.
8. Cadigan K., Nusse R. Wnt signaling: a common theme in animal development. Genes Dev. 11:1997;3286-3305.
9. Crisp T.M., Clegg E.D., Cooper R.L. et al. Enviromental endocrine disruption: an effects assessment and analysis. Environ. Health Perspectives. 106(suppl.):1998;11-52.
10. Cunha G.R. Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the Müllerian ducts and urogenital sinus during development of the uterus and vagina in mice. J. Exp. Zool. 196:1976;361-370.
11. Cunha G.R. Epithelial-stromal interactions in development of the urogenital tract. Int. Rev. Cytol. 47:1976;137-194.
12. Forsberg J.G., Kalland T. Embryology of the genital tract in humans and in rodents. Herbst A.L., Bern H.A. Developmental Effects of Diethylstilbestrol (DES) in Pregnancy. 1981;4-25 Thieme-Stratton, NewYork.
13. Gavin B.J., McMahon A.P. Differential regulation of the Wnt gene family during pregnancy and lactation suggests a role in postnatal development of the mammary gland. Mol. Cell Biol. 12(5):1992;2418-2423.
14. Gavin B.J., McMahon J.A., McMahon A.P. Expression of multiple novel Wnt-1/int-1-related genes during fetal and adult mouse development. Genes Dev. 4(12B):1990;2319-2332.
15. Haney A.F., Hammond C.B., Soules M.R., Creasman W.T. Diethylstilbestrol-induced upper genital tract abnormalities. Fertil. Steril. 31(2):1979;142-146.
16. Heinonen O.P. Diethylstilbestrol in pregnancy: frequency of exposure and usage pattern. Cancer. 31:1973;573.
17. Herbst A.L., Anderson S., Hubby M.M.e.a. Risk factors for the development of diethylstilbestrol associated clear cell adenocarcinoma: a case control study. Am. J. Obstet. Gynecol. 154:1986;814-822.
18. Herbst A.L., Scully R.E., Robboy S.J. Vaginal adenosis and other diethylstilbestrol-related abnormalities. Clin. Obstet. Gynecol. 18(3):1975;185-194.
19. Iguchi T., Takasugi N. Postnatal development of uterine abnormalities in mice exposed to DES in utero. Biol. Neonate. 52:1987;97-103.
20. Iguchi T., Takase M., Takasugi N. Development of vaginal adenosis-like lesions and uterine epithelial stratification in mice exposed perinatally to diethylstilbestrol. Proc. Soc. Exp. Biol. Med. 181:1986;59-65.
21. Kaufman R.H., Binder G.L., Gray P.M., Adam E. Upper genital tract changes associated with exposure in utero to diethylstilbestrol. Am. J. Obstet. Gynecol. 128(1):1976;51-59.
22. Kessel M., Gruss P. Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid. Cell. 67:1991;89-104.
23. Lindenau A., Fischer B., Seiler P., Beier H.M. Effects of persistent chlorinated hydrocarbons on reproductive tissues in female rabbits. Hum. Reprod. 9(5):1994;772-780.
24. McLachlan J.A., Newbold R.R., Bullock B.C. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res. 40:1980;3988-3999.
25. Miano J.M., Cserjesi P., Ligon K.L., Periasamy M., Olson E.N. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ. Res. 75:1994;803-812.
26. Miller C., Sassoon D.A. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development. 125:1998;3201-3211.
27. Miller C., Pavlova A., Sassoon D.A. Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech. Dev. 76:1998;91-99.
28. Miller C., Degenhardt K., Sassoon D.A. Fetal exposure to DES results in de-regulation of Wnt-7a during a critical period of uterine morphogenesis. Nature Genet. 20:1998;228-230.
29. Mishina Y., Rey R., Finegold M.J., Matzuk M.M., Josso N., Cate R.L., Behringer R.R. Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev. 10(20):1996;2577-2587.
30. Moon R.T., Brown J.B., Torres M.T. Wnts modulate cell fate and behavior during vertebrate development. Trends Genet. 13(4):1997;157-162. NCl Clinical Trials Website - http://cancertrials.nci.nih.gov.
31. Mortlock D.P., Innis J.W. Mutation of HOXA13 in hand-foot-genital syndrome. Nature Genet. 15:1997;179-180.
32. Newbold R.R., McLachlan J.A. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol. Cancer Res. 42:1982;2003-2011.
33. Newbold R., Hanson R., Jefferson W., Bullock B., Haseman J., McLachlan J. Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis. 19:1998;1655-1663.
34. Newbold R., Jefferson W., Padilla-Burgos E., Bullock B. Uterine carcinoma in mice treated neonatally with tamoxifen. Carcinogenesis. 18:1997;2293-2298.
35. Nusse R., Varmus H.E. Wnt genes. Cell. 69(7):1992;1073-1087.
36. Nusse R., Brown A., Papkoff J., Scamber P., Shackleford G., McMahon A., Moon R., Varmus H. A new nomenclature for int-1 and related genes: the Wnt gene family. Cell. 64:1991;231.
37. Nusse R., van Ooyen A., Cox D., Fung Y.K., Varmus H. Mode of proviral activaton of a putative mammary oncogene (int-1) on mouse chromosome 15. Nature. 307:1984;131-136.
38. Parr B.A., McMahon A.P. Dorsalizing signal Wnt-7a required for normal polarity of D-V and A-P axes of mouse limb. Nature. 374(6520):1995;350-353.
39. Parr B., McMahon A. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature. 395:1998;707-710.
40. Parr B.A., Shea M.J., Vassileva G., McMahon A.P. Mouse Wnt genes exhibit discrete domains of expression in the early embryonic CNS and limb buds. Development. 119(1):1993;247-261.
41. Pavlova A., Boutin E., Cunha G., Sassoon D. Msx1 (Hox-7.1) in the adult mouse uterus: cellular interactions underlying regulation of expression. Development. 120:1994;335-346.
42. Safe S.H. Is there an association between exposure to environmental estrogens and breast cancer? Environ. Health Perspect. 3(suppl 105):1997;675-678.
43. Sonnenschein C., Soto A. An updated review of environmental estrogen and androgen mimics and antagonists. J. Steroid Biochem. Mol. Biol. 65:1998;143-150.
44. Tsukamoto A.S., Grosschedl R., Guzman R.C., Parslow T., Varmus H.E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell. 59:1988;619-625.
45. Weber-Hall S.J., Phippard D.J., Niemeyer C.C., Dale T.C. Developmental and hormonal regulation of Wnt gene expression in the mouse mammary gland. Differentiation. 57(3):1994;205-214.